Biosimilars Market : Press Release Distribution

News Jan 03, 2024

Global Biosimilars Market Size Was Valued at USD 36 Billion in 2022, and is Projected to Reach USD 102.69 Billion by 2030, Growing at a CAGR

News Nov 27, 2023

Biosimilars Market was valued at USD 9630 million in 2021 and is expected to reach USD 55410 million by the year 2028, at a CAGR of 28.4%.

Biology Nov 22, 2023

Biosimilars Market 2023 Overview, Growth Forecast, Demand and Development Research Report to 2030

Business Sep 05, 2023

BiosimilarsMarket 2023 Overview, Growth Forecast, Demand and Development Research Report to 2029

Business Sep 01, 2023

BiosimilarsMarket 2023 Overview, Growth Forecast, Demand and Development Research Report to 2029

Health Jun 21, 2023

Oncology Biosimilars Market was valued at US$ 4 Billion, and is likely to rise at a Y-o-Y growth rate of 5% in 2022 to reach US$ 4.2 Billion

Business Jun 05, 2023

Biosimilars Market Segmented By Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins Product Type for Hematology, Growth

Business Apr 05, 2023

Biosimilars Market Size And Forecast | Pfizer, Novartis, Biocon, Biogen, Fresenius Kabi AG, Boehringer Ingelheim, Merck KgaA, Mylan, Eli Lil

Business Apr 05, 2023

Monoclonal antibodies (mAbs) Biosimilars Market Size And Forecast | Biocon, Celltrion, Dr. Reddy's Laboratories, Hospira, 3SBio, Accord Heal

Business Mar 24, 2023

Glycosylated Biosimilars Market Size And Forecast | Sandoz, Pfizer, Teva Pahrmaceutical, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan,

Business Mar 24, 2023

Recombinant Non Glycosylated Proteins Biosimilars Market Size And Forecast | Sandoz, Pfizer, Teva Pahrmaceutical, Celltrion, Biocon, Amgen,

Business Mar 23, 2023

Oncology Biosimilars Market Size And Forecast | Celltrion, Biocon, Dr. Reddyï¿½ï¿½s Laboratories, STADA Arzneimittel AG, Intas Pharmac

Business Mar 21, 2023

Biosimilars Market Size And Forecast | Pfizer, Novartis, Biocon, Biogen, Fresenius Kabi AG, Boehringer Ingelheim, Merck KgaA, Mylan, Eli Lil

Industry Mar 21, 2023

A biosimilar is a biological product that is very similar to a reference biologic and for which there are no clinically meaningful differenc

Business Mar 16, 2023

Retinal Biosimilars Market Size And Forecast | Novartis (Sandoz), Takeda, Bayer, Genentech, Pfenex, Reliance Life Sciences, Hetero Drugs, In

Business Mar 15, 2023

G-CSF and G-CSF Biosimilars Market Size And Forecast | Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, Glax